Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Solventum CorpSOLV · Entity 1645 | Chief Accounting Officer | May 13, 2026 | May 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Solventum Corp
Report date May 13, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,904 |
Ending reported balance
After 2026-05-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-13 · Exercise / conversion · Acquired 2,376 · Balance 7,632 Row 2 · 2026-05-13 · Tax withholding · Disposed 728 · Balance 6,904 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2034-05-13 | Direct | 2,377 |
Reported balance
After 2026-05-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-13 · Exercise / conversion · Disposed 2,376 · Balance 2,377 F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F2: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2026 Filed May 15, 2026 20:09 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionRestricted Stock Units · Derivative | 2,376 | $0.00 | $0.00 |
DisclosureSEC source: 0002016061-26-000005 · wk-form4_1778875789.xml · derivative · entry 3 Wilcox Mary T · CIK 0002016061 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,377 Underlying: Common Stock · 2,376 shares Expires 2034-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:09 UTC | Solventum Corp SOLV · Entity 1645 | Tax withholdingCommon Stock | 728 | $74.41 | $54,170.48 |
DisclosureSEC source: 0002016061-26-000005 · wk-form4_1778875789.xml · nonDerivative · entry 2 Wilcox Mary T · CIK 0002016061 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,904 Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:09 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionCommon Stock | 2,376 | $0.00 | $0.00 |
DisclosureSEC source: 0002016061-26-000005 · wk-form4_1778875789.xml · nonDerivative · entry 1 Wilcox Mary T · CIK 0002016061 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2026 Filed Mar 30, 2026 23:45 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionRestricted Stock Units · Derivative | 5,199 | $0.00 | $0.00 |
DisclosureSEC source: 0002016061-26-000003 · wk-form4_1774914319.xml · derivative · entry 3 Wilcox Mary T · CIK 0002016061 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,199 shares Expires 2034-08-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs are fully vested. Read SEC document |
| March 27, 2026 Filed Mar 30, 2026 23:45 UTC | Solventum Corp SOLV · Entity 1645 | Tax withholdingCommon Stock | 1,591 | $62.76 | $99,851.16 |
DisclosureSEC source: 0002016061-26-000003 · wk-form4_1774914319.xml · nonDerivative · entry 2 Wilcox Mary T · CIK 0002016061 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,256 Read SEC document |
| March 27, 2026 Filed Mar 30, 2026 23:45 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionCommon Stock | 5,199 | $0.00 | $0.00 |
DisclosureSEC source: 0002016061-26-000003 · wk-form4_1774914319.xml · nonDerivative · entry 1 Wilcox Mary T · CIK 0002016061 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:22 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionRestricted Stock Units · Derivative | 2,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-025963 · wk-form4_1747340562.xml · derivative · entry 3 Wilcox Mary T · CIK 0002016061 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,753 Underlying: Common Stock · 2,375 shares Expires 2034-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:22 UTC | Solventum Corp SOLV · Entity 1645 | Tax withholdingCommon Stock | 727 | $73.52 | $53,449.04 |
DisclosureSEC source: 0001628280-25-025963 · wk-form4_1747340562.xml · nonDerivative · entry 2 Wilcox Mary T · CIK 0002016061 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,648 Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:22 UTC | Solventum Corp SOLV · Entity 1645 | Exercise / conversionCommon Stock | 2,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-025963 · wk-form4_1747340562.xml · nonDerivative · entry 1 Wilcox Mary T · CIK 0002016061 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 20:19 UTC | Solventum Corp SOLV · Entity 1645 | GrantRestricted Stock Units · Derivative | 5,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-022192 · form4.xml · derivative · entry 1 Wilcox Mary T · CIK 0002016061 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,199 Underlying: Common Stock · 5,199 shares Expires 2034-08-12 F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest on March 27, 2026, subject to continued service through the vesting date. Read SEC document |
| May 13, 2024 Filed May 15, 2024 21:08 UTC | Solventum Corp SOLV · Entity 1645 | GrantRestricted Stock Units · Derivative | 7,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015505 · form4.xml · derivative · entry 1 Wilcox Mary T · CIK 0002016061 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,128 Underlying: Common Stock · 7,128 shares Expires 2034-05-13 F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.